Steven Feldman
Site Head & Scientific Director GMP Facility
Steven Feldman, Site Head & Scientific Director, Laboratory of Cell and Gene Medicine (Stanford GMP Facility), oversees all aspects of Stanford’s academic GMP operations including process development, manufacturing, analytical methods development, quality control, and quality assurance. With expertise spanning cell therapies, gene therapies, and CRISPR-based T cell editing, Steven leads diverse development programs including CAR-T therapies, NK cell therapies, and transplant support services. His work focuses on process optimization, automation implementation, and tech transfer strategies to increase manufacturing throughput while supporting clinical translation from academic research to commercial partnerships and hospital-based cell therapy facilities.
Seminars
- Integrating automation across manufacturing and analytical testing to reduce turnaround time and achieve competitive advantage in increasingly crowded therapeutic markets
- Scaling automated autologous production from an initial two to three patients per week to hundreds globally while maintaining reliability and meeting contractual delivery commitments
- Reducing the cost of goods from half a million dollars per patient lot to small fractions through comprehensive automation to ensure long-term commercial sustainability
